Taken together, these studies underline the central role of MMP-9 in the development of trigeminal neuralgia and provide a strong foundation for exploring new treatment options, with MMP-9 inhibition emerging as a particularly promising approach. The gene discussed is MMP9; the disease is trigeminal nerve disorder.